EAGAN, Minn.--(BUSINESS WIRE)--Gastrointestinal cancer expert Eric Van Cutsem, M.D., Ph.D., has joined the Biothera Clinical Advisory Board. Biothera is conducting clinical trials with Imprime PGG®, a non-chemotherapeutic drug that enhances monoclonal antibody efficacy through targeted innate immune cell activation.
